Isabelle De Smedt focuses her practice on the U.S. Foreign Corrupt Practices Act (FCPA), the U.K. Bribery Act (UKBA), and related anti-corruption and fraud matters. As a licensed practitioner in Belgium and working primarily in Brussels, Isabelle has extensive regulatory compliance experience crucial to guiding multinational clients through complex transactions and government enforcement actions. She has substantial experience working with clients in the United States, Africa, Asia, Europe, and Latin America.
Isabelle is licensed to practice in Belgium and is a member of the Brussels Bar (List A). She is not admitted to practice in New York or licensed to practice law in the United States.
A large part of my international practice involves assisting clients with respect to the FCPA, the UKBA, and other anti-corruption laws. This includes offering compliance advice in relation to compliance issues when they arise. I work with clients to develop and implement effective anti-bribery and anti-corruption compliance programs, and to provide training sessions to their personnel located throughout the world. I conduct and supervise anti-corruption due diligence into prospective and existing third-party agents, distributors, and other business partners, as well as in connection with cross-border mergers, acquisitions and joint ventures. I regularly lead risk assessments and internal investigations. I also guide clients through enforcement proceedings and government investigations when they arise.
My practice also involves cross-border transactions for multinational companies. I work with numerous international corporations, including many Belgian companies, on complex mergers, acquisitions, joint ventures, corporate restructures and reorganizations. I also counsel clients with respect to complex contract and corporate disputes.
I have a deep understanding and knowledge of, among others, the health care and life sciences industries, including contract research organizations (CROs), which I use to tailor my work to individual client’s needs and preferences.
The Department of Justice (DOJ) remains focused on prosecuting FCPA violations. Recent updates to DOJ enforcement policy and guidance, as well as newly announced settlements with FCPA violators, show that the DOJ is intently focused on how companies are developing, implementing, and managing their anti-corruption compliance regimes. The clear takeaway from the current enforcement climate is that anti-corruption policies that exist on paper only are inadequate. The DOJ expects companies to actively manage and customize their compliance programs.
Law360 | August 28, 2019
New York City partner Isabelle De Smedt (CORP), Manchester partner Mark Knights (GIWC), Boston counsel Robert Fisher (GIWC), Manchester associate Michael Strauss (CDPG) and Boston associate Scott Seitz (GIWC) authored this column about the U.S. Court of Appeals for the Second Circuit’s recent decision regarding the Foreign Corrupt Practices Act’s anti-bribery provisions and what the decision means for companies needing to comply with the law.
The Anti-Corruption Report | May 29, 2018
Corporate partners Alexandra Lopez-Casero and Isabelle de Smedt are quoted in this article discussing the business consequences of the Global Magnitsky Act, a new anti-corruption statute.
Law360 | July 16, 2017
The article focuses on the arrival of M&A and corporate transactions partners John Erwin Brian Brown, Angie Cottrell and Isabelle de Smedt, and paralegal Patricia Harris as well as the firm’s Raleigh office.
American Lawyer | July 09, 2017
The following coverage is about the arrival of M&A and corporate transactions partners John Erwin, Brian Brown, Angie Cottrell and Isabelle De Smedt to Nixon Peabody’s new Raleigh, North Carolina office.
Government Investigations & White-Collar Defense Alert | 11.13.19
Government Investigations & White Collar Defense Alert | 10.07.19
Government Investigations & White Collar Defense Alert | 08.15.19
Government Investigations & White Collar Defense Alert | 05.22.19
Sanctions/Foreign Corrupt Practices Alert | 02.01.18
Foreign Corrupt Practices Act Alert | 11.29.17